Dr. Reddy's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Dr. Reddy's Laboratories has a total shareholder equity of ₹309.3B and total debt of ₹43.8B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are ₹466.0B and ₹156.7B respectively. Dr. Reddy's Laboratories's EBIT is ₹67.7B making its interest coverage ratio -227.8. It has cash and short-term investments of ₹63.1B.
Key information
14.2%
Debt to equity ratio
₹43.82b
Debt
| Interest coverage ratio | -227.8x |
| Cash | ₹63.07b |
| Equity | ₹309.28b |
| Total liabilities | ₹156.67b |
| Total assets | ₹465.96b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500124's short term assets (₹248.1B) exceed its short term liabilities (₹129.3B).
Long Term Liabilities: 500124's short term assets (₹248.1B) exceed its long term liabilities (₹27.4B).
Debt to Equity History and Analysis
Debt Level: 500124 has more cash than its total debt.
Reducing Debt: 500124's debt to equity ratio has reduced from 19.3% to 14.2% over the past 5 years.
Debt Coverage: 500124's debt is well covered by operating cash flow (77.7%).
Interest Coverage: 500124 earns more interest than it pays, so coverage of interest payments is not a concern.